Lanton Law

Lanton Law Blog

Learn about the latest trends and activities through our blog posts.

Posts tagged 2020 Election
Election May Determine Pace of Biosimilar Legislation
Election May Determine Pace of Biosimilar Legislation

We have a new article out with the Center for Biosimilars titled “Election May Determine Pace of Biosimilar Legislation.”

Read More
biologics, Biosimilars, healthcare, life sciences, pharmaceuticals, pharmacy, prescription drug costs, star ratingsRon LantonCongress, H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act, Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars (ACCESS Act), Preserve Access to Affordable Generics and Biosimilars Act, Affordable Prescriptions for Patients Through Improvements to Patient Litigation Act, Affordable Prescriptions for Patients Act of 2019, 2020 Election